Boldt, Simone <br/><br/>
The role of MAPK pathways in the action of chemotherapeutic drugs.  [electronic resource] 

 -  Carcinogenesis  Nov 2002 
 - 1831-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-3334 
<br/><br/><label>Standard No.: </label>10.1093/carcin/23.11.1831  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--pathology<br/>Carcinoma, Squamous Cell--pathology<br/>Cell Cycle--drug effects<br/>Ceramides--pharmacology<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Etoposide--pharmacology<br/>Female<br/>Flavonoids--pharmacology<br/>HeLa Cells--drug effects<br/>Humans<br/>Imidazoles--pharmacology<br/>MAP Kinase Signaling System--drug effects<br/>Microtubules--drug effects<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Paclitaxel--pharmacology<br/>Pyridines--pharmacology<br/>Skin Neoplasms--pathology<br/>Topoisomerase II Inhibitors<br/>Tumor Cells, Cultured--drug effects<br/>Tumor Stem Cell Assay